- Euglycemic Diabetic Ketoacidosis When Reducing Insulin Dosage in Patients Taking Sodium Glucose Cotransporter 2 Inhibitor
-
Yi WJ, Kim SK, Youn SU, Kang N, Lee MW, Park SO
- KMID: 2367898
- Ewha Med J.
- 2017 Jan;40(1):55-58.
- doi: 10.12771/emj.2017.40.1.55
Sodium glucose cotransporter 2 (SGLT2) inhibitor has been recently reported of diabetic ketoacidosis due to accumulation of ketone bodies in patients with severe dehydration caused from such like diarrhea even... -
- CITED
-
- Close
- SHARE
-
- Close
